New Jersey 2024-2025 Regular Session

New Jersey Senate Bill S1865

Introduced
1/9/24  
Introduced
1/13/26  
Refer
1/9/24  

Caption

Exempts sales of certain baby products from sales and use tax.

Impact

If passed, S1865 will modify the current legal classification of several fentanyl derivatives. The addition of these illicit fentanyls to Schedule I means that any unlawful manufacturing, distributing, or dispensing of these substances in significant quantities will carry severe legal penalties. As these substances are deemed extremely dangerous, this classification will empower law enforcement to address the proliferation of their use more effectively. However, the bill notably does not alter the current designation of prescription fentanyl, which remains a Schedule II substance, thus differentiating between medically supervised use and illegal distribution.

Summary

Senate Bill S1865 proposes to add 'illicit fentanyls' to Schedule I of the New Jersey Controlled Dangerous Substances Act. By doing so, the bill aims to legally recognize these substances, which are known for their high potential for abuse and lack of accepted medical use in treatment. This legislative move is a direct response to the increasing drug abuse crisis in New Jersey, specifically targeting the rise of synthetic opioids that have contributed heavily to overdose deaths across the state. The bill reinforces existing legal frameworks aimed at regulating dangerous substances and ensuring public health safety.

Sentiment

The sentiment surrounding S1865 is largely supportive among public health advocates, who view this bill as a necessary measure to combat the opioid crisis. Many stakeholders believe that recognizing the dangers of these synthetic substances is crucial for public safety. However, there may be some opposition from individuals concerned about potential overreach in drug policy. The bill's passage could foster a greater dialogue about the complexities of substance regulation and its implications for individuals suffering from addiction.

Contention

A notable point of contention within discussions surrounding S1865 may revolve around the balance between public safety and the stigma associated with addiction. Critics may argue that the emphasis on criminalization could impede efforts in harm reduction and treatment for those struggling with substance use disorders. The ongoing debate in the legislature is likely to reflect broader concerns about ensuring that the fight against drug-related issues remains compassionate and focuses not just on punitive measures but also on effective rehabilitation strategies.

Companion Bills

NJ A196

Same As Exempts sales of certain baby products from sales and use tax.

NJ A5547

Carry Over Exempts sales of certain baby products from sales and use tax.

NJ A998

Carry Over Codifies and expands ARRIVE Together Pilot to make certain mental health services available to police responding to certain emergencies; appropriates $2 million.

NJ S617

Carry Over Prohibits imposition of builder's remedy in exclusionary zoning litigation.

Previously Filed As

NJ S1745

Exempts grooming and hygiene products and certain baby products from sales and use tax.

NJ A216

Exempts grooming and hygiene products and certain baby products from sales and use tax.

NJ S1034

Exempts sales of bandages and other similar products from sales and use tax.

NJ S1906

Exempts sales of pet food and medication purchased for pets from sales and use tax.

NJ SB183

Sales and Use Taxes; certain baby products from taxation; exempt

NJ HB1536

Retail Sales and Use Tax; exemption for certain baby products.

NJ A3845

Exempts oral healthcare products from sales and use tax.

NJ S2464

Exempts oral healthcare products from sales and use tax.

NJ S487

Exempts sales of energy-saving products and services from sales and use tax.

NJ SB539

Sales and Use Taxes; certain baby products and feminine hygiene products from taxation; exempt

Similar Bills

No similar bills found.